Europe’s medical devices industry saw a drop of 20.00% in deal activity during July 2022

Europe’s medical devices industry saw a drop of 20% in deal activity during July 2022, when compared with the last 12-month average, led by Peninsula Capital Partners’ $143.03m acquisition of Red Kiwi, according to GlobalData’s deals database.

A total of 32 medical devices industry deals worth $318.3m were announced for the region in July 2022, against the 12-month average of 40 deals.

Of all the deal types, venture financing saw most activity in July 2022 with 16 transactions, representing a 50% share for the region.

In second place was M&A with 12 deals, followed by private equity deals with four transactions, respectively capturing a 37.5% and 12.5% share of the overall deal activity for the month.

In terms of value of deals, venture financing was the leading category in Europe’s medical devices industry with $169.93m, while private equity and M&A deals totalled $145.05m and $3.35m, respectively.

Europe medical devices industry deals in July 2022: Top deals

The top five medical devices deals accounted for 88.7% of the overall value during July 2022.

The combined value of the top five medical devices deals stood at $282.4m, against the overall value of $318.3m recorded for the month.

The top five medical devices industry deals of July 2022 tracked by GlobalData were:

1) Peninsula Capital Partners $143.03m private equity deal with Red Kiwi

2) The $100m venture financing of Kerecis ehf by Emerson Collective (Emmerson Collective) and KIRKBI Invest

3) SCR,BNP Paribas Développement SA,Cathay Capital,Credit Mutuel Innovation and Kurma Partners $21.45m venture financing deal with Ganymed Robotics

4) The $10.09m venture financing of PreciPoint by bm-t beteiligungsmanagement thuringen

5) NEST pension fund,Swiss Diabetes Venture Fund,Verve Ventures and Zurcher Kantonalbank $7.83m venture financing deal with Piomic Medical